Clinical trial
Escitalopram Treatment of Patients With Agitated Dementia
NCT00260624 · University of Rochester, Other · Completed
Key facts
| NCT number | NCT00260624 |
|---|---|
| Title | Escitalopram Treatment of Patients With Agitated Dementia |
| Official title | Escitalopram in the Treatment of Patients With Agitated Dementia |
| Lead sponsor | University of Rochester, Other |
| Collaborators | Forest Laboratories Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Alzheimer's Disease, Psychomotor Agitation |
| Intervention type | Drug |
| Interventions | Escitalopram (Lexapro) |
| Enrollment | 20 |
| Start date | Feb 1, 2003 |
| Primary completion | Dec 1, 2006 |
| Completion | Dec 1, 2006 |
| First posted | Dec 1, 2005 |
| Last update posted | Feb 24, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: